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Abstract
Invasive fungal infections by Candida albicans (Ca) are a frequent cause of lethal sepsis in intensive care unit patients. While
a contribution of type I interferons (IFNs-I) in fungal sepsis remains unknown, these immunostimulatory cytokines mediate
the lethal effects of endotoxemia and bacterial sepsis. Using a mouse model lacking a functional IFN-I receptor (Ifnar12/2),
we demonstrate a remarkable protection against invasive Ca infections. We discover a mechanism whereby IFN-I signaling
controls the recruitment of inflammatory myeloid cells, including Ly6Chi monocytes and neutrophils, to infected kidneys by
driving expression of the chemokines CCL2 and KC. Within kidneys, monocytes differentiate into inflammatory DCs but fail
to functionally mature in Ifnar12/2 mice, as demonstrated by the impaired upregulation of the key activation markers
PDCA1 and iNOS. The increased activity of inflammatory monocytes and neutrophils results in hyper-inflammation and
lethal kidney pathology. Pharmacological diminution of monocytes and neutrophils by treating mice with pioglitazone, a
synthetic agonist of the nuclear receptor peroxisome proliferator-activated receptor-c (PPAR-c), strongly reduces renal
immunopathology during Ca infection and improves mouse survival. Taken together, our data connect for the first time the
sepsis-promoting functions of IFNs-I to the CCL2-mediated recruitment and the activation of inflammatory monocytes/DCs
with high host-destructing potency. Moreover, our data demonstrate a therapeutic relevance of PPAR-c agonists for
microbial infectious diseases where inflammatory myeloid cells may contribute to fatal tissue damage.
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Introduction
Fungal sepsis is a frequent cause of death in the intensive care
unit, with Candida spp. being among the most common microbial
pathogens isolated from septic patients. Worldwide, C. albicans (Ca)
represents the most prevalent isolate recovered from human
candidemic patients. The inflammatory response and disease
progression of invasive candidiasis presents a similar clinical
picture as seen for bacterial sepsis, with some patients developing
septic shock and organ dysfunction, the most common of which is
acute renal failure [1].
Type I interferons (IFNs-I) constitute a family of pleiotropic
cytokines that regulate resistance to viruses, enhance innate and
adaptive immunity, and modulate cell survival and apoptosis [2].
The most relevant members include IFN-b, with only one member
in humans and mice, and the IFN-a family encompassing more
than 10 members. While IFNs-I strongly protect against viral
infections, they can have either protective or detrimental host
effects in bacterial infections depending on the pathogen in
question [3]. In comparison, little is known about their contribu-
tions in fungal infections. We and others have recently reported
that mouse bone marrow-derived dendritic cells (BM-DCs)
produce IFN-b in response to Candida spp. in vitro [4,5]. Notably,
the IFN-I receptor subunit IFNAR1 is among the highest
upregulated genes in blood leukocytes in a mouse model of
invasive candidiasis [6]. Furthermore, similar to bacterial infec-
tions, recent reports suggest that IFNs-I are implicated in the in vivo
response to fungal pathogens, albeit with opposing effects for the
host [7,8]. The divergent functions of IFNs-I may relate to their
versatile effects on antimicrobial immunity and to their ability to
trigger either inflammatory or anti-inflammatory responses
depending on the particular pathological situation [9].
Besides modulating innate and adaptive immune responses,
IFNs-I play a critical role in promoting lethal endotoxemia and
sepsis. For instance, mice lacking the IFN-I receptor (Ifnar12/2) are
highly insensitive to LPS- or TNF-induced lethal shock [10,11].
Notably, they also show improved survival in a model of septic
peritonitis [12]. However, the concept of IFNs-I as adverse
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mediators of sepsis has been challenged by a recent study using a
low lethality model of cecal ligation and puncture-induced sepsis
[13]. In this model, Ifnar12/2mice show an increased late mortality,
underlining the complex effects of IFNs-I. The apparent discrep-
ancies might relate to differences in the temporal regulation of the
IFN-I response, the amount or subtype of cytokines produced or the
microbial species used within a certain model [14].
This work addresses the pathophysiological role of IFN-I
signaling during Ca infections using an intravenous (iv) mouse
challenge model. As in humans, the mouse kidney is the prime
target organ, as progressive sepsis concomitant with renal failure
account for mortality in that model [15]. Since the severity of
kidney tissue damage is quantitatively related to the level of host
innate response, it has been suggested that an uncontrolled
inflammatory response rather than Ca itself may worsen disease
outcome. Indeed, massive infiltrations of neutrophils are com-
monly observed and believed to contribute significantly to host
tissue destruction [16].
Another highly inflammatory cell type frequently associated
with host immunopathologies are Ly6Chi inflammatory monocytes
[17–19]. The chemokine CCL2 recruits inflammatory monocytes
to infected body sites, where they exert direct anti-microbial
activities or further differentiate into inflammatory DCs [20]. This
DC subtype participates in the protective innate response and is
characterized by high production of TNF-a and iNOS [21].
Interestingly, IFNs-I have been shown to regulate Ly6Chi
monocyte recruitment during viral infections [22,23], as well as
during chronic inflammation in mice [19] by inducing Ccl2.
However, the role of inflammatory monocytes in the host response
to Ca infections remains unknown.
Here, we demonstrate a pivotal role of IFNs-I in triggering the
inflammatory host response and immunopathology in experimen-
tal candidiasis. We establish a mechanism through which IFNs-I
mediate the lethal effects of Ca-induced sepsis. IFN-I signaling
stimulates the recruitment of both Ly6Chi inflammatory mono-
cytes and neutrophils from the bone marrow to infected kidneys.
Furthermore, IFN-I signaling is required for the subsequent
maturation of monocytes into functional inflammatory DCs. Thus,
mice competent for IFN-I signaling (WT) suffer from unrestrained
hyper-inflammation, resulting in lethal kidney pathology. In sharp
contrast, Ifnar12/2 mice are remarkably resistant to otherwise
lethal Ca infections, and show reduced activity of inflammatory
myeloid cells. Strikingly, the pharmacological suppression of
inflammatory monocytes and neutrophils by the anti-diabetes
drug pioglitazone, a PPAR-c agonist, strongly reduces renal
immunopathology and improves survival of mice, suggesting a
novel therapeutic option to combat fungal sepsis. Our data
provide a molecular mechanism explaining the manifestation and
progression of systemic fungal infections. We suggest that
interfering with the activity of inflammatory monocytes and
neutrophils provides beneficial effects for disease outcome by
suppressing fatal kidney pathology during Ca infections. Impor-
tantly, our results are the first report of a central role of the IFN-I-
driven CCL2/CCR2 pathway in controlling inflammatory
monocyte trafficking during fungal infections.
Results
Detrimental role of IFN-I signaling in a Candida
intravenous infection mouse model
We have recently shown that Candida spp. induce an IFN-b
response in mouse BM-DCs [4]. To test for in vivo production of
IFNs-I upon systemic Candida infections, we infected WT and
IFNAR1-deficient mice with Ca by lateral tail vein injection (iv).
Both infected mouse genotypes produced similar levels of IFN-a
with increasing cytokine levels upon disease progression
(Figure 1A). We were unable to detect serum IFN-blevels under
the same experimental conditions, since IFN-b is notoriously
known for its low expression levels in vivo and thus remained below
the detection limit. Nevertheless, BM-DCs from both WT and
IFNAR1-deficient mice produced equal levels of IFN-b upon Ca
stimulation (Figure S1A). Unlike WT cells, Ifnar12/2 BM-DCs
failed to respond to IFN-b as evident from the absence of STAT1
phosphorylation. (Figure S1B).
To examine a contribution of IFN-I signaling on the infection
outcome and fungal dissemination, we compared the survival of WT
and Ifnar12/2 animals infected with various Ca loads. Interestingly,
at a dose of 105 Ca colony-forming units (cfus) the lack of IFNAR1
caused a remarkable protection to otherwise lethal infections, which
became apparent after one week of injection (Figure 1B). The same
phenotype was observed after infection with lower fungal doses of
0.56105 Ca cfus (Figure S1C), whereas increasing the fungal loads to
56105 Ca cfus obliterated the protective effect of IFNAR1-
deficiency (Figure S1D). Thus, the beneficial effect of lacking an
IFN-I response is only evident under infection conditions that do not
overburden host protective capacity.
To test whether the improved survival of Ifnar12/2 mice was a
result of increased fungal clearance, we determined fungal burdens
in the major organs of infected animals. To avoid premature death
of WT mice before sample collection, we infected mice with
0.56105 Ca cfus. At indicated time points, spleen, liver, brain and
kidneys were collected and analysed for the presence of fungal cells
by cfu counting. During the first week of infection, Ca cfus
remained high only in the kidneys (Figure 1C), which is in
agreement with previous findings [24,25]. In all other organs,
fungal burden was controlled by the immune system and either
stayed low (brain) or progressively decreased over time (spleen and
Author Summary
Inflammation constitutes a major host response in many
microbial infections. Innate immune cells orchestrate the
inflammatory response to kill pathogens and clear infec-
tions. However, invasive infections by pathogenic mi-
crobes including the fungus Candida albicans, can result in
an uncontrolled hyper-inflammatory response, leading to
severe host damage and sepsis. Type I interferons
constitute a hallmark of protective innate immunity in
viral and bacterial infections, but at the same time have
been notoriously known for their sepsis-promoting effects
in numerous experimental inflammation models. Here, we
show that type I interferon-signaling mediates the lethal
hyper-inflammatory response during systemic mouse
infections with C. albicans. Following fungal infections,
type I interferons promote the recruitment and activation
of inflammatory monocytes and neutrophils to infected
organs. The high abundance and activity of inflammatory
phagocytes lead to fatal tissue damage. Remarkably, we
show that the pharmacological suppression of these
inflammatory cells with the drug pioglitazone reduces
immunopathology and sepsis-related lethality, suggesting
a novel therapeutic option to combat fungal sepsis. In
conclusion, our data couple the sepsis-promoting role of
type I interferons to the host-destructive activity of
inflammatory monocytes and neutrophils. We propose
that therapeutic approaches dampening hyper-inflamma-
tion might be of general importance in microbial diseases
where deleterious immunopathology occurs.
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liver) suggesting successful clearance (Figure S1E). For any organ
investigated, we did not observe a significant difference in Ca cfus
between WT and Ifnar12/2 mice. We also investigated the in vitro
Ca killing capacity of host phagocytes with suspected or known
functions in the clearance of fungal infections. Again, we did not
observe significant differences in the in vitro Ca killing capacities of
phagocytes from WT or Ifnar12/2 mice (Figure 1D). In
conclusion, we demonstrate that Ca-induced IFN-I signaling
mediates detrimental host effects during disseminated and invasive
infections, though not by altering fungal clearance. These data
suggest that other mechanisms confer resistance to systemic Ca
infections in a host with defective IFN-I signaling.
IFN-I signaling augments the inflammatory host response
to Candida
We hypothesized that Ifnar12/2 mice may be more resistant to
Ca infections because IFN-I signaling is able to enhance
deleterious inflammatory responses. Therefore, we quantified
sepsis-relevant inflammatory mediators in serum and kidney, the
critical target organ, during the first week of Ca infection. In
support of our hypothesis, Ifnar12/2 mice showed significantly
reduced serum levels of inflammatory TNF-a and IL-6 when
compared to WT mice (Figure 2A). Furthermore, blood counts
revealed considerably lower leukocyte numbers in Ifnar12/2 mice,
indicating an attenuated infection-induced haematopoiesis. In
particular, granulocyte counts were significantly lower (Figure 2B),
suggesting an impaired or delayed granulopoesis in knock-out
animals. By contrast, total lymphocyte numbers did not differ
significantly at any time point (Figure 2B). Taken together, these
results demonstrate that IFN-I signaling triggers an early systemic
release of inflammatory cytokines and contributes to the Ca-
induced robust granulopoesis.
As observed for the systemic inflammatory response, early IL-6
levels were significantly reduced at day 1 post infection in kidneys
of Ifnar12/2 mice when compared to WT animals (Figure 2C). We
also quantified expression levels of additional inflammation
mediators with a known involvement in acute kidney injury
[26], including the major adhesion molecules ICAM-1 and P-
Selectin. In agreement with attenuated inflammation, we detected
reduced renal expression of these adhesins in Ifnar12/2 mice
(Figure 2C). The decrease of these critical cytokines and adhesion
molecules in kidneys of knock-out mice strongly suggested a
reduced immune cell infiltration in the infected organ. To test this
notion, we isolated leukocytes from Ca-infected kidneys and
evaluated the total number of immune cells (CD45+) and myeloid
cells (CD11b+). In line with the reduced granulopoesis, Ifnar12/2
kidneys displayed significantly lower numbers of infiltrating
leukocytes, which could be attributed to the selective reduction
of myeloid cells within the tissue (Figure 2D). In summary, our
results indicate that IFN-I signaling strongly promotes both
systemic and acute local inflammatory responses in Ca-infected
mice by enhancing the expression of pro-inflammatory mediators,
as well as the recruitment of innate immune cells.
IFNs-I promote kidney injury through unrestrained host
responses
To investigate the pathological consequences of the IFN-I-
mediated inflammatory response, we examined the immunohisto-
Figure 1. Ca induces a detrimental IFN-I response during infection. (A) Mice of the indicated genotype were iv injected with a lethal dose of
16105 cfus Ca. Serum was collected at indicated time points, and IFN-a concentrations were determined using a multiplex bead array system. Data
presented show the mean 6 SEM of two independent experiments (n = 6–8 mice per group). (B) Mice were injected as in (A) and survival was
monitored for 35 days. The data are presented as Kaplan-Meier survival curves and are a summary of three independent experiments (n = 16 mice per
group). (C) Mice were injected with 0.56105 cfus Ca. At indicated time points, Ca cfus in kidneys were determined and expressed as cfus/g organ.
Data presented are a summary of three independent experiments (n = 3–15 mice per group). Each symbol represents one mouse; horizontal bars
indicate the calculated median. (D) Resting and activated peritoneal macrophages (PMs), exudate neutrophils (N), and bone marrow neutrophils (BM-
N) were stimulated with Ca at the indicated multiplicities of infection and for indicated time periods. Percentage of Ca killing was determined by
counting cfus. Data presented are from single experiments with at least 4 replica wells per condition.
doi:10.1371/journal.ppat.1002811.g001
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pathology of infected kidneys from WT and Ifnar12/2 mice.
Histopathological inspection at day 1 after infection revealed
typical Ca-containing abscesses in the renal cortex including
massive phagocyte infiltrates. There were no obvious differences in
the quality and quantity of fungal lesions in WT vs. Ifnar12/2 mice
at this early stage of infection (Figure 3A). However, at day 3, Ca-
containing abscesses were still abundantly present in WT mice but
were mainly cleared in IFNAR1-deficient animals (Figure 3A). At
day 7, the inflammatory process in WT animals spread to the renal
tubules and pelvis with extensive tubular cast formation and
distortion of the renal architecture. By contrast, there were almost
no fresh cellular casts detectable in Ifnar12/2 mice (Figure 3A).
Notably, at that time point, no more Ca cells were detectable
within the renal cortex of WT or Ifnar12/2 mice. Thus, the
continuous immune cell recruitment to the renal cortex can be
considered an over-reactive host response that may promote
kidney pathology.
To test whether the observed damage of renal architecture also
impaired kidney function, we measured the expression level of
kidney injury molecule-1 (Kim-1) in kidneys, as well as urea levels
in serum of infected animals. Kim-1 expression strongly increases
in de-differentiated renal proximal tubular epithelial cells upon
tissue damage, and is thus a suitable biomarker for early kidney
injury [27]. Strikingly, Kim-1 expression levels peaked at day 3 of
Figure 2. IFN-I signaling promotes hyper-inflammatory immune responses.Mice of the indicated genotype were injected with a lethal dose
of 16105 cfus Ca. At indicated time points, serum/whole blood and kidneys were collected. (A) Sera concentrations of IL-6 and TNF-a were measured
using a multiplex bead array system. Data presented show the mean 6 SEM of four independent experiments (n = 7–12 mice per group). (B) Blood
cell populations were analysed by an automated blood counter. Data presented show the mean 6 SEM of two independent experiments (n = 6–8
mice per group). Plotted are the absolute numbers of leukocytes, granulocytes, and lymphocytes expressed as cell number 6109/l. (C) IL-6
concentrations in kidney supernatants were measured using a multiplex bead array system. Gene expression levels of Icam-1 and P-Selectin were
quantified by qPCR in kidney total RNA. Data presented show the mean 6 SEM of three independent experiments (n = 7–12 mice per group). (D)
Kidney leukocytes were enriched and characterized by multi-label flow cytometry. Graphs show absolute numbers of leukocytes (CD45+) and myeloid
cells (CD11b+) per total mouse kidneys. Data presented is one representative of two independent experimental repeats (n = 3–5 mice per group).
doi:10.1371/journal.ppat.1002811.g002
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infection and were much higher in WT mice when compared to
mice lacking IFNAR1 (Figure 3B). The peak of Kim-1 expression
coincided with the presence of Ca lesions in the WT kidney,
preceding the subsequent kidney damage, which was evident from
the increased urea levels at day 7 (Figure 3C). Taken together, the
data let us conclude that IFN-I signaling drives unrestrained
inflammatory responses in Ca-infected kidneys, as indicated by the
prolonged presence of immune cell infiltrates/fungal abscesses and
the abundant formation of cellular casts at later stages of infection.
This hyper-inflammatory response increases organ damage
as demonstrated by higher expression of Kim-1 and serum urea
levels.
IFNs-I mediate the recruitment of inflammatory
phagocytes to the infected kidney
To identify the cell types contributing to the kidney damage, we
thought to determine kidney recruitment kinetics for major
immune cell types frequently implicated in inflammatory condi-
tions, including neutrophils [28], inflammatory monocytes [29,30]
and T cells [31,32]. Therefore, we enriched infiltrating leukocytes
from kidneys of Ca-infected WT or Ifnar12/2 mice to characterize
and quantify the different leukocyte populations by flow cytom-
etry, using common immune cell markers (Table S1 in Text S1).
As previously observed by others, kidney infections by Ca followed
a two-phase innate response [25]. At day 1, neutrophils and
inflammatory monocytes accumulated to equal amounts in
kidneys of WT mice (Figure 4A). The influx of inflammatory
monocytes was transient, peaking at day 1 and declining
thereafter. In contrast, neutrophils showed a second wave of
massive infiltration starting between day 3 and 5 post infection
(Figure 4A). T cells numbers also increased throughout disease,
but remained only a minor fraction of the total cell population
within the infected kidney (Figure S2A and B). Whereas the
recruitment pattern of CD8+ and CD4+ T cells was comparable
between WT and Ifnar12/2 mice (Figure S2A and B), inflamma-
tory phagocyte infiltrates were significantly less in kidneys of
knock-out mice (Figure 4A). Interestingly, Ifnar12/2 mice
displayed significantly lower numbers of inflammatory monocytes
and neutrophils during early infection stages and lacked the late
massive neutrophil influx (Figure 4A). We further confirmed the
lack of neutrophil influx by measuring MPO levels in kidney
homogenates. MPO is an oxidative granular enzyme found
primarily in neutrophils and is therefore used to quantify tissue
neutrophil content [33]. In agreement with reduced neutrophil
numbers, MPO levels remained low in Ifnar12/2 kidneys at day 7
post infection (Figure S2C). We further confirmed the apparent
recruitment defect of monocytes and neutrophils using an
intraperitoneal (ip) Ca infection model, which is commonly used
Figure 3. Reduced immunopathology protects Ifnar12/2 mice from kidney injury. Mice of the indicated genotype were injected with a
lethal dose of 16105 cfus Ca. At indicated time points, serum and kidneys were collected. (A) Histopathology of the cortical part of kidneys at day 1, 3
and 7 post infection. Longitudinal sections of paraffin-embedded organs were stained with periodic acid-Schiff (PAS) to visualize fungal cells.
Counterstaining was performed with hematoxylin. (n = 3–4 mice per group) (B) Kidney total RNA was analysed for gene expression of kidney injury
marker-1 (Kim-1). Data presented show the mean 6 SEM of three independent experiments (n = 8–10 mice per group). (C) Urea concentration in
serum. Data presented show the mean 6 SEM of two independent experiments (n = 7–9 mice per group).
doi:10.1371/journal.ppat.1002811.g003
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to assess leukocyte infiltrations to sites of infection [34,35]. As
expected, we observed significantly reduced peritoneal cell
infiltrations in IFNAR1-deficient mice (Figure 4B). Since the cell
frequencies of peritoneal Ly6Chi monocytes and neutrophils were
similar between WT and Ifnar12/2 mice (Figure 4B), we
concluded that the recruitment of both cell types is equally
affected by the absence of IFN-I signaling.
Altered expression levels of the respective cell-specific chemo-
kines also reflected the impaired innate cell recruitment to infected
kidneys. Coinciding with the peak of inflammatory monocytes,
Ccl2 expression levels were strongly reduced in kidneys of
Ifnar12/2 mice (Figure 4C). Likewise, the early expression of the
neutrophil chemokine KC was diminished in knock-out animals
(Figure 4D). In contrast, the late neutrophil influx seemed to be
independent of KC signaling, since both WT and Ifnar12/2 mice
displayed comparable levels of the chemokine at day 7. Locally
produced IL-1b represents another chemo-attractant signal for
neutrophils during inflammatory conditions [36]. As expected
from the increased neutrophil accumulations, we also detected
elevated expression levels of IL-1b in kidneys of WT mice
(Figure 4E). Increased IL-1b levels coincided with the peak of
KIM-1 expression and occurred just prior to the second wave of
neutrophil influx. Together, these data indicate that IFN-I
signaling promotes the early recruitment of neutrophils and
inflammatory monocytes into Ca-infected kidneys. Elevated
numbers of inflammatory cells during the first days of infection
seem to drive a late massive influx of neutrophils, which is absent
in Ifnar12/2 animals.
Figure 4. IFN-I signaling promotes inflammatory phagocyte influx to infected sites. (A, C–E) Mice of the indicated genotype were injected
with a lethal dose of 16105 cfus Ca. At indicated time points, kidneys were collected. (A) Kidney leukocytes were enriched and characterized by multi-
label flow cytometry. Graphs show absolute numbers of inflammatory monocytes and neutrophils per total mouse kidneys (left) and percent of
CD45+ cells (right). Data presented is one representative of two independent experimental repeats (n = 3–5 mice per group). (B) Mice of the indicated
genotype were ip injected with a sublethal dose of 16107 cfus Ca. After 4–6 h, peritoneum was flushed and cell number was determined by CASY-
counting. Analysis of Ly6G+ and Ly6C+ peritoneal cells from WT versus Ifnar12/2 mice (dot plot). (C) Kidney total RNA was analysed for gene
expression of Ccl2. (D) KC concentrations in kidney supernatants were measured using a multiplex bead array system. Both (C) and (D) show the mean
6 SEM of three independent experiments (n = 7–12 mice per group). (E) Kidney total RNA was analysed for gene expression of Il-1b. Data presented
show the mean 6 SEM of three independent experiments (n = 7–12 mice per group).
doi:10.1371/journal.ppat.1002811.g004
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IFN-I signaling controls recruitment and activation of
inflammatory monocytes
The regulation of inflammatory monocyte trafficking and anti-
microbial defense during fungal infections remains unexplored.
Emigration of Ly6Chi monocytes from the bone marrow (BM) is
known to require signaling via the CCR2 receptor. Notably, the
induction of the cognate chemokine ligands such as CCL2, CCL7,
and CCL8 are regulated by IFNs-I in certain infectious diseases
[22,23].
Since we had observed a strongly reduced expression of CCL2
in Ca-infected kidneys of Ifnar12/2 mice, we thought to investigate
the IFNAR1-dependent expression of the chemokine in more
detail. Monocytes are known as high producers of chemokines,
including CCL2 [22]. Therefore, we stimulated GM-CSF-
differentiated BM-DC cultures, which contain about one third
Ly6C+ monocytes (Figure 5A), with heat-inactivated Ca and
determined the release of the two major monocyte-attracting
chemokines CCL2 and CCL7 [37]. Whereas BM-derived WT
Ly6C+ monocytes released CCL2 and CCL7 upon Ca challenge,
IFNAR1-deficient cells were strongly impaired in their chemokine
response (Figure 5A). The release of IFN-b was similar under all
conditions, ensuring equal responsiveness of cells (data not shown).
We confirmed the IFNAR1-dependent induction of CCL2/CCL7
in WT cells pre-treated with an anti-IFNAR1 blocking antibody
prior to Ca stimulation (Figure S3A). As a control, pre-treatment
of WT cells with an unspecific isotype IgG did not alter CCL2
production (data not shown).
In line with the kidney chemokine data, we also observed a
reduced expression of two neutrophil-attracting chemokines, KC
and MIP-2, in Ca-stimulated Ifnar12/2 BM-DC cultures
(Figure 5A), although neither chemokine is a classical IFN-
stimulated gene. Interestingly, simply blocking IFNs-I signaling
with the anti-IFNAR1 antibody was not sufficient to reduce the
release of KC and MIP-2 (Figure S3A), suggesting that the
physical presence of a functional IFN-I receptor, rather than its
signaling function, cooperates with other pathways for full
activation of neutrophil-specific chemokines.
During infections with microbial pathogens, the initial CCL2
production is triggered in the BM, where it mediates inflammatory
monocyte egression into the blood stream [4]. Therefore, we
examined whether Ca could induce the local production of CCL2
in the BM. To determine whether Ca resides within the BM during
infection, we measured cfu counts of infected WT and Ifnar12/2
mice. In accordance with previous reports [38], we confirmed that
fungal cells are present in the BM. As for other organs, the BM
fungal burden did not differ between WT and knock-out animals
(Figure 5B). To test whether Ca-infected BM releases CCL2, we
isolated BM cells from infected WT and Ifnar12/2 mice at day 1
and cultured them for a total of 3 days. At the time of BM isolation
cellular composition and viability of cells were the same between
both mouse genotypes (data not shown). Thereafter, we quantified
the daily release of CCL2 into the media. Again, we observed a
requirement of IFNs-I for full CCL2 production in Ca-infected BM,
which became even more evident after longer periods of culture
(Figure 5C). Similar results were obtained for the gene expression
levels of Ccl2 and Ccl7 in infected BM. At day 3 post infection, the
induction of monocyte-attracting chemokines was strongly reduced
in absence of IFNAR1 signaling (Figure S3B).
We hypothesized that the diminished CCL2/CCL7 production
in the BM of Ifnar12/2 mice may result in a mobilization defect of
inflammatory monocytes. Therefore, we determined the number
of circulating inflammatory monocytes in the blood of infected
WT and Ifnar12/2 mice. Indeed, we found significantly reduced
inflammatory monocyte counts in the blood of IFNAR1-deficient
mice (Figure 5D and 5E). In summary, these data establish CCL2/
CCL7 as IFN-I-dependent chemokine signals driving the host
response during systemic candidiasis. Through regulating the
expression of these chemokines in the BM and the kidneys, IFNs-I
contribute to the mobilization of inflammatory monocytes into the
blood stream and their subsequent migration to the target organ.
In the context of inflammation, Ly6Chi monocytes differentiate
into inflammatory DCs within the tissue [39]. Thus, we were
interested to test if monocyte-derived inflammatory DCs are also
generated during invasive Ca infections. Therefore, we further
characterized Ly6Chi kidney monocytes for common inflamma-
tory DC surface and activation markers using flow cytometry.
Cells from both WT and Ifnar12/2 mice expressed high levels of
CCR2, the hallmark receptor of inflammatory monocytes, as well
as the two major DC markers CD11c and MHCII (Figure 5F). In
infected WT kidneys, inflammatory DCs showed upregulated
expression of the activation marker PDCA1 (Figure 5F), as well as
extensive intracellular iNOS staining (Figure 5G). Strikingly, in the
absence of IFN-I signaling, PDCA1 expression and iNOS+ cell
numbers were significantly reduced. The defect in inducing iNOS
gene expression was also confirmed by qPCR in infected kidneys
of Ifnar12/2 mice (Figure 5H). We confirmed these results in vitro
by stimulating GM-CSF-differentiated BM-DCs with heat-inacti-
vated Ca. As for inflammatory DCs in the kidney, we observed a
lack of PDCA1 and iNOS expression in the IFNAR1-deficient
Ly6C+ monocyte population (Figure S3C). Similar results were
obtained in WT cultures that had been pre-treated with an anti-
IFNAR1 blocking antibody prior to Ca-challenge (Figure S3D).
Again, the levels of CD11c or MHC class II were not affected by
the absence of IFN-I signaling (Figure S3C and D). All together,
we demonstrate that Ly6Chi monocyte differentiate into inflam-
matory DCs during invasive Ca infections. Whereas the initial
differentiation into DCs seems to be independent of IFN-I
signaling, our results suggest a novel role for IFNs-I in the
functional maturation of inflammatory DCs based on the
appearance of specific activation markers.
Reducing inflammatory myeloid cell numbers protects
mice from lethal Ca challenge
IFNs-I promote the inflammation-associated lethal kidney
pathology during systemic Ca infections by stimulating the
recruitment and activation of Ly6Chi monocytes and neutrophils.
However, both cell types are essential for fungal clearance and
total elimination renders mice hyper-susceptible to infection [40].
Based on our findings, we hypothesized, that interfering with the
activity of these cell types rather than the total elimination would
ameliorate host tissue damage and thereby improve the overall
outcome of infection. Published evidence suggests that the drug
pioglitazone, a synthetic agonist of the nuclear receptor PPAR-c,
impairs inflammatory DC trafficking and associated lung pathol-
ogy in an influenza mouse model [17]. To test our hypothesis, we
treated mice daily with 5 mg/kg pioglitazone or vehicle starting on
the day of Ca infection. Strikingly, pioglitazone-treated mice were
strongly protected against lethal Ca challenge and experienced a
reduced weight loss when compared to non-treated animals
(Figure 6A). No significant differences in kidney fungal loads where
found between the two mouse groups (data not shown).
To determine whether the protective effect of pioglitazone
correlated with an inhibition of inflammatory myeloid cell
recruitment, we determined Ly6Chi monocyte and neutrophil
numbers in blood and kidneys. In the bloodstream, pioglitazone
treatment specifically reduced inflammatory monocyte numbers,
while total granulocyte numbers were not affected (Figure S4A).
However, in the kidneys, early accumulation of both inflammatory
Type I Interferons Promote Fatal Candida Sepsis
PLoS Pathogens | www.plospathogens.org 7 July 2012 | Volume 8 | Issue 7 | e1002811
monocytes and neutrophils was equally reduced in drug-treated
animals (Figure 6B). In addition to cell recruitment, we
investigated the effect of pioglitazone treatment on the activation
of inflammatory DCs in infected kidneys. In line with previous
reports identifying iNOS as one of the main target genes of PPAR-
c mediated repression [41], we detected significantly reduced
iNOS+ inflammatory DCs in kidneys of drug-treated mice
(Figure 6C), suggesting that pioglitazone also interferes with the
Figure 5. IFN-I signaling regulates Ly6Chi monocytes recruitment and activation. (A) Expression of Ly6C and CD11c on GM-CSF-
differentiated BM-DCs at day 8 of culture (dot plot). BM-DCs of the indicated genotypes were stimulated with heat-inactivated Ca. After 24 h, CCL2,
CCL7, KC, and MIP-2 release was determined by ELISA or a multiplex bead array system. Data presented show the mean6 SEM of three independent
experiments. (B–H) Mice of the indicated genotype were injected with a lethal dose of 16105 cfus Ca. At indicated time points, blood, BM and
kidneys were collected. (B) Ca cfus in BM were determined and expressed as cfus/mouse bones (n = 3–5 mice per group). Each symbol represents one
mouse; horizontal bars indicate the calculated median. (C) BM from day 1-infected mice was isolated and placed in culture. At indicated time points,
CCL2 release into the media was measured (n = 3 mice per group). (D) Expression of Ly6C and CD11b on blood leukocytes at day 5 of Ca infection in
WT versus Ifnar12/2 mice. Inflammatory monocytes were gated in R1. (E) Quantification of cells in the R1 gate at different time points post infection.
Depicted are percent inflammatory monocytes of total WBCs (left) and absolute cell numbers in6107/l blood (right). (n = 3–5 mice per group) (F–G)
Kidney leukocytes were enriched and characterized by multi-label flow cytometry. (F) Expression of Ly6C and CD11b on kidney leukocytes at day 1 of
Ca infection. Inflammatory monocytes are gated in R2 (dot plot). Expression of the inflammatory DC surface markers CCR2, CD11c, MHC II, and PDCA1
by cells in the R2 gate. Solid lines, staining of R2 cells of day 1-infected mice; shaded histograms, for CCR2: staining with isotype control antibody, for
CD11c and MHCII: staining of CD11c2MHCII2 neutrophils, for PDCA1: staining of R2 cells of uninfected mice. Data presented are representatives of
three independent experimental repeats (total n = 11–14 mice per group). (G) Kidney leukocytes at day one of infection were stained intracellularly
for iNOS. Graphs show iNOS+ cells (green) overlayed on total CD45+ leukocytes (black). Bar diagram shows the quantification of iNOS+ cells in percent
of total CD11b+ cells. Data presented show the mean 6 SEM of two independent experiments (n = 8–9 mice per group). (H) Kidney total RNA was
analysed for gene expression of iNOS. Data presented show the mean 6 SEM of three independent experiments (n = 7–12 mice per group).
doi:10.1371/journal.ppat.1002811.g005
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functional maturation of inflammatory DCs. The inhibition of
iNOS expression could be reproduced in vitro, since stimulating
pioglitazone pre-treated BM-DCs with heat-inactivated Ca (Figure
S4B) led to similar reductions in iNOS expression. Strikingly, the
reduced early cell infiltration in kidneys resulted in the absence of
the late detrimental neutrophil influx (Figure 6D). Hence,
pioglitazone treatment improves kidney damage by diminishing
local inflammation, which was evident by reduced serum urea
levels at day 5 (Figure 6E). Although there was a general decrease
in the magnitude of inflammation in drug-treated animals, the
measurements for IL-6 and Ccl2 in blood and kidney (Figure S4C)
did not reach statistical significance due to high variability between
mice. Nevertheless, pioglitazone pre-treatment significantly re-
duced CCL2 and CCL7 release from Ca-stimulated BM-DCs in a
dose-dependent manner (Figure 6F), whereas production of KC
and MIP-2 was not influenced by the treatment (Figure S4D). A
cytotoxic effect of pioglitazone was excluded by live-dead staining
of cells after drug treatment (Figure S4E). Interestingly, in addition
to monocyte-attracting chemokines, pioglitazone also decreased
the initial release of IFN-b by BM-DCs (Figure 6F). This
observation prompted us to investigate whether the reduced
release of CCL2/CCL7 results from the impaired IFN-b
production. Therefore, we pre-treated Ifnar12/2 BM-DCs with
pioglitazone and examined if the remaining release of chemokines
from these cells was further decreased by the drug. Pioglitazone
treatment was able to even further suppress the production of
CCL2 in IFNAR1-deficient cells (Figure S4F). Therefore, the
suppressive function on chemokine expression must be a direct
effect of the PPAR-c-mediated transcription inhibition of those
genes [42], without involving secondary IFN-b signaling.
Taken together, our results suggest that the usage of PPAR-c
agonists might represent a novel therapeutic option to improve
survival of a host in the setting of an emerging fungal sepsis. On
the basis of our collective data, we therefore propose the following
model for the IFN-I-regulated detrimental activity of inflammatory
myeloid cells during experimental candidiasis (Figure 7). Recog-
nition of Ca by innate immune cells in the bone marrow initiates
the IFN-I–CCL2 cytokine-chemokine cascade and stimulates
mobilization of inflammatory monocytes from the bone marrow
to the infected organs. Simultaneously, infection-triggered gran-
ulopoiesis induces the proliferation and mobilization of neutro-
phils. Monocytes and neutrophils migrate towards the infected
kidneys where CCL2 and KC are produced in an IFNAR1-
dependent manner. Inside the renal tissue, inflammatory mono-
cytes acquire a DC-like phenotype through a process not requiring
IFN-I signaling. However, the subsequent activation of inflamma-
tory DCs to become high producers of iNOS strictly depends on a
functional IFN-I response. High abundance and activity of
inflammatory cells causes early tissue damage, leading to the
subsequent massive accumulation of neutrophils, whose destruc-
tive power ultimately leads to kidney failure. The genetic
deficiency of IFNAR1 or the pioglitazone-mediated pharmaco-
logical suppression of inflammatory cell recruitment and activation
strongly improves Ca-mediated immunopathology and survival of
the host.
Discussion
The present study demonstrates a detrimental effect of IFNs-I
during invasive experimental candidiasis. We show that IFN-I
Figure 6. Pioglitazone suppresses lethal inflammatory phagocyte activity. WT mice were injected with a lethal dose of 16105 cfus Ca and
treated daily with 5 mg/kg pioglitazone. (A) Survival and mean percentage of original body weight of drug-treated versus vehicle-treated mice are
presented. Data presented show the sum of two independent experimental repeats (n = 13–16 mice per group). (B) Kidney leukocytes were enriched
and absolute numbers of inflammatory monocytes and neutrophils determined. Each symbol represents one mouse; horizontal bars indicate the
calculated median (n = 6 mice per group). (C) Kidney leukocytes at day 1 of infection were intracellularly stained for iNOS. Bar diagram shows the
quantification of iNOS+ cells in percent of total CD11b+ cells, mean 6 SEM (n = 6 mice per group). (D) Absolute numbers of neutrophils in kidneys of
treated vs non-treated mice. Each symbol represents one mouse; horizontal bars indicate the calculated median (n = 4–5 mice per group). (E) Urea
concentration in serum, mean 6 SEM (n= 4–5 mice per group). (F) BM-DCs were pre-treated overnight with indicated concentrations of pioglitazone
and stimulated with heat-inactivated Ca the next day. After 24 h of Ca co-incubation, CCL2, CCL7, and IFN-b release were measured by ELISA. Data
presented show the mean 6 SEM of 3 independent experiments.
doi:10.1371/journal.ppat.1002811.g006
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signaling stimulates the recruitment of inflammatory innate
immune cells, including Ly6Chi monocytes and neutrophils, into
the infected kidney, which promote lethal hyper-inflammatory and
tissue-damaging immune responses in mice. Importantly, we
establish a pharmacological approach by interfering with the
activity of those inflammatory cells, which ameliorates disease
progression and improves survival of otherwise lethal fungal
infections.
In many microbial infections, a disregulated or overshooting
immune response rather than the pathogen itself can cause fatal
host damage. Likewise, studies comparing host responses to
attenuated and virulent Ca strains suggest that fungus-induced
inflammation contributes considerably to tissue damage and
mortality [16]. The lack of IFN-I signaling in Ifnar12/2 mice
constrains hyper-inflammatory immune reactions and improves
survival of mice infected with Ca. Hence, our data support the
notion that uncontrolled host responses rather than the fungal
growth are a primary cause of death in the murine Candida
infection model. Since Ifnar12/2 mice exhibit similar fungal
burdens in critical organs when compared to WT animals, the
sepsis resistance phenotype may result from increased host
tolerance to the pathogen burden. Therefore, the Ifnar12/2
mouse model would represent an excellent tool to study virulence
factors of Ca, allowing for the mechanistic distinction between
tissue damage caused by fungal dissemination versus the hyper-
inflammatory host response.
Similar to bacterial infections, IFNs-I can exert both beneficial
and detrimental effects during fungal diseases [7,8]. We have
previously reported a role for IFNs-I in supporting persistence of
Candida glabrata (Cg) within the host. Contrasting with their effects
in our Ca infection model, fungal persistence of Candida glabrata
may arise from an IFN-I-mediated attenuated host response,
Figure 7. IFNs-I regulate detrimental Ly6Chi monocyte and neutrophil activity. Model of IFN-I-mediated monocyte/neutrophil recruitment
and activation of inflammatory DC during invasive Ca infections. Ca recognition triggers an IFN response, which controls the production of various
chemokines, including CCL2 and KC, at different anatomical body sites (BM and kidneys). In response to local CCL2 in the BM, Ly6Chi monocytes exit
into the blood stream and migrate towards the target organ where they differentiate into inflammatory DCs. To fully functionally mature and become
iNOS-producing cells, DCs require signaling through IFNAR1. The high presence and activity of inflammatory DCs and neutrophils in the kidney
during the early infection phase promotes a secondary strong influx of neutrophils culminating in lethal immunopathology. The suppressive action of
pioglitazone on Ly6Chi monocyte/neutrophil recruitment and function ameliorates hyper-inflammation and kidney pathology.
doi:10.1371/journal.ppat.1002811.g007
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which facilitates immune evasion by the fungus [4]. This of course
implies that specific ‘‘patterns of pathogenesis’’ are exploited by
different pathogens, including the use of distinct virulence
strategies to generate pathogen-specific contextual cues during
infection, which decide about the balance of pro- versus anti-
inflammatory functions of IFNs-I. Although a recent study
identified Ifnar12/2 mice as hyper-susceptible to disseminated
Ca infections, different fungal strains and infection doses, as well as
mouse genetic backgrounds, may explain the discrepancy [5].
Indeed, different microbial loads and injection routes may
influence the outcome of infection regardless of the genetic
phenotype in the host, which normally determines the capacity of
immune surveillance [43,44].
IFNs-I may dictate a pro- or anti-inflammatory response in host
cells depending on the initial IFN-I concentrations targeting
responder cells [45,46]. We report severely reduced levels of
inflammatory mediators and innate immune cells in blood and
kidneys of Ifnar12/2 mice upon Ca infection, suggesting a pro-
inflammatory role of IFNs-I in this infection model. Notably,
IFNs-I have been reported to exert an inhibitory effect on
inflammasome activation and the subsequent release of pro-
inflammatory IL-1bin mice. The resulting impairment of inflam-
mation-mediated protective immunity renders mice hyper-suscep-
tible to invasive Ca infections [47]. In this mouse model, however,
massive IFN-I production was pre-induced with repeated injec-
tions of poly-IC prior to fungal infection. We believe that the
mechanistic difference to our model is explained by the level of
IFNs-I induced between the different challenges, thereby changing
the ratio of inflammatory versus anti-inflammatory effector
functions. Indeed, in our infection model, where IFNs-I are not
produced prior to fungal challenge, we are unable to detect an
IFN-I-mediated inhibition of IL-1bproduction. Consistent with
our model, we observe unchanged or even lower concentrations of
IL-1b in kidney homogenates of Ifnar12/2 mice.
Invasive Ca infections progress mainly in the kidneys and the
consequent organ damage likely contributes to the overall
pathology of disease [48]. Thus, we focused on the immune
response and pathology of the kidney to further investigate the
organ-specific inflammatory response to Ca. Interestingly, we
show a significantly reduced early accumulation of myeloid cells,
including inflammatory monocytes and neutrophils, and a lack of
the second massive neutrophil infiltration in kidneys of IFNAR1-
deficient animals. While IFN-I signaling seems to play a general
role in promoting monocyte recruitment, as evident from other
studies [19,22,49], their effects on neutrophil trafficking and
function are quite divergent between different infection models
[12,13,50]. Similar to our Ca infection model, IFNs-I mediate the
recruitment of both inflammatory monocytes and neutrophils into
kidneys during experimental glomerulonephritis [51]. Also in this
model, the consequent higher abundance of myeloid cells worsens
disease pathology, indicating the detrimental role of monocytes
and neutrophils in kidney function. In future studies it will be
interesting to delineate the individual contributions of monocytes
and neutrophils to Ca-induced kidney immunopathology by
adopting antibody-mediated depletion strategies. One may spec-
ulate that early tissue damage caused by the activity of
inflammatory innate cells triggers the second wave of neutrophil
influx in our infection model. There is evidence that danger signals
generated through cellular damage at the site of inflammation
attract neutrophils. Many of these danger signaling pathways
converge on IL-1b as a key orchestrator of inflammation and cell
recruitment [36]. Indeed, we detect higher IL-1b expression levels
in kidneys of WT animals when compared to Ifnar12/2 mice.
Likewise neutrophils, inflammatory monocytes/DCs have been
implicated in the immunopathology of various diseases, including
infectious or autoimmune diseases [52]. In other fungal infection
models, including respiratory aspergillosis and cryptococcosis,
monocytes contribute to the instruction of protective T cell
immunity and Th cell differentiation [53,54]. Inflammatory
monocytes emigrate from the BM through CCR2 receptor-
mediated signaling and accumulate at the sites of infection [37,55].
We show here that IFNs-I control the recruitment of Ly6Chi
monocytes by inducing CCL2/CCL7 expression both in the BM
and the target organ, strongly increasing inflammatory monocyte
counts in blood and kidneys of Ca-infected WT mice. Bone
marrow mesenchymal stem and progenitor cells are the initial
producers of CCL2 and inducers of monocyte emigration during
infections [56]. Notably, during infections with Listeria monocyto-
genes, IFNAR1 does not contribute to the early monocyte
emigration from the BM within the first 24 hours [57]. Our data
confirm the early IFNAR1-independent induction of monocyte-
attracting chemokines in the BM during the early response.
However, at later stages of infection, IFNs-I become central
mediators of CCL2/CCL7 production and monocyte egression.
Hence, the IFN-I-driven CCL2/CCR2 pathway is of general
importance for controlling inflammatory monocyte recruitment
during microbial infectious diseases.
Due to a defect of monocyte egression from the BM, mice
lacking CCL2 or the cognate receptor CCR2 retain most
monocytes in the BM [37,55]. In contrast to Ccr22/2 or
Ccl22/2 mice, Ifnar12/2 mice do not show this retention
phenotype, most likely because IFN-I signaling might also affect
the primary differentiation or proliferation of monocytes within
the BM [58]. Upon arrival in the infected tissue, Ly6Chi
monocytes further differentiate into inflammatory DCs to execute
their anti-microbial defense [21,55]. In addition to the impaired
recruitment of inflammatory monocytes, Ifnar12/2 mice show
defects in the activation of inflammatory DCs, as evident by their
reduced PDCA1 and iNOS expression. Whereas iNOS is a well-
established functional marker of inflammatory DCs, a PDCA1+
inflammatory-like DC subset has been only recently associated
with higher expression of pro-inflammatory cytokines and
increased T cell-stimulatory potential [59]. IFNs-I have been
known for their capacity to differentiate human blood monocytes
in vitro into a special DC subset, termed IFN-DCs [60].
Interestingly, the ability of IFNs-I to tip the balance in monocyte
terminal differentiation has been also noted during chronic
inflammation [19], where IFNs-I sustain the inflammatory
conditions by inhibiting the terminal differentiation of monocytes
into anti-inflammatory tissue macrophages, perhaps by promoting
their differentiation into inflammatory DCs. Since inflammatory
monocytes seem to carry out several central functions in anti-
fungal immunity, including propagation of inflammation and T
cell instruction, it will be of particular interest to establish a
possible role of these cells during fungal diseases in the patient
setting, including the search for genetic polymorphisms in CCR2
or CCL2 that might modulate the outcome of fungal infections.
Notably, SNPs in STAT1, a key mediator of both IFN-I and IFN-
II (IFN-c) signaling, are implicated in the outcome of invasive
fungal infections in humans [61].
Here, we show that pharmacological suppression of monocytes
and neutrophils as achieved by treating mice with pioglitazone, a
synthetic agonist of the nuclear receptor PPAR-c, can rescue
animals from Ca-mediated immunopathology. Stimulating PPAR-
c antagonizes inflammatory responses by repressing the transcrip-
tional activation of NFkB target genes, including CCL2, TNF-a
and iNOS [62,63]. Interestingly, a prophylactic pioglitazone
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treatment has been recently adopted to reduce detrimental
inflammatory DC infiltration into the lungs during influenza virus
infections [17]. Strikingly, we demonstrate here that pioglitazone
treatment of Ca-infected mice reduces the early accumulation of
inflammatory monocytes, as well as neutrophils in kidneys.
Furthermore, treatment also strongly impairs the neutrophil influx
at later stages of infection. The drug also suppresses the activation
of inflammatory DCs, thereby diminishing organ inflammation.
Thus, pioglitazone treatment precisely phenocopies the observa-
tions in Ifnar12/2 mice, including the reduced inflammatory cell
recruitment and functional maturation of inflammatory DCs.
Activation of individual nuclear receptors is believed to repress
specific subsets of inflammatory target genes with different
functions, resulting in distinct biological consequences for the host
response [64]. Notably, our data indicate that pioglitazone
represses a specific gene subset in vivo, which seems to overlap
with the IFN-I target genes driving the lethal inflammation during
invasive candidiasis. Previous studies have revealed that pioglita-
zone treatment rescues mice from lethal influenza virus infections
and reduces disease activity of septic peritonitis or murine lupus
[17,62,65]. In support of the beneficial effects of pioglitazone, we
show that treatment of Ca-infected mice ameliorates renal
immunopathology and improves animal survival.
Our data suggest that the modulation of Ly6Chi monocyte and
neutrophil numbers, as observed for Ifnar12/2 and pioglitazone-
treated mice, has beneficial effects for the host by dampening the
hyper-inflammation. The detrimental immunopathology most
likely results from the biphasic recruitment and activation of
inflammatory monocytes and neutrophils, both of which contrib-
ute to the fatal kidney pathology. In support of our hypothesis,
depletion of Gr1+ cells at day 7 of Ca infection, which removes
both monocytes and neutrophils, increases survival of mice [40].
Taken together, our work identifies IFN-I signaling as a central
mediator of inflammatory innate immune cell migration into
infected organs, demonstrating a pivotal yet detrimental role for
IFNs-I in fungal pathogenesis in vivo. The inflammatory cascade
driven by the sustained expression of IFN-I-regulated inflamma-
tory genes substantially contributes to tissue damage observed in
infected mice. The pharmacological suppression of inflammatory
monocytes and neutrophils shows that interfering with those cell
types during invasive Ca infections improve immunopathology
and disease outcome. Thus, this work expands the spectrum of
detrimental inflammatory immune cells during Ca infections
beyond neutrophils. Our study provides a novel mechanism for
the role of IFNs-I in sepsis progression, coupling IFN-I target
genes such as CCL2 and iNOS to the recruitment and activation
of inflammatory monocytes/DCs with considerable host-destruc-
tive potential. The direct connection between IFNs-I and
inflammatory monocytes might be of general importance in
microbial diseases where an IFN-I response is detrimental for the
host. We propose that the beneficial effects of PPAR-c agonists
may also apply to other infectious diseases where inflammatory




All animal experiments were discussed and approved through
the University of Veterinary Medicine Vienna institutional ethics
committee and carried out in accordance with animal experimen-
tation protocols approved by the Austrian law (GZ 680 205/67-
BrGt/2003, GZ-BMWF-68.205/0233-II/10b/2009 and GZ-
BMWF-68.205/0231-II/3b/2011).
Fungal strains and growth conditions
The Candida albicans (Ca) strain used in this study was the
standard clinical isolate SC5314 [67]. Fungal cells were grown to
the logarithmic growth phase in single-use, pyrogen- and
endotoxin-free sterile flasks. For detailed information see supple-
mental text and materials.
Mouse models and pioglitazone treatment
Ifnar12/2 mice on C57BL/6 background [68] were bred at
Biomodels Austria, University of Veterinary Medicine. C57BL/6
wild type controls were purchased from Charles River. Mice were
housed under specific pathogen-free conditions according to
FELASA guidelines. Male mice were challenged on day 0 via
the lateral tail vein with 16105 Ca colony-forming units (cfus) per
21 g body weight, if not otherwise stated. Fungal load was adjusted
to individual mouse weights. For survival experiments, mice were
monitored for 14–35 days. Groups of mice were sacrificed on
different days post infection (p.i.) for analysis of macroscopic and
histological changes, fungal organ burden, and changes in the
levels of cytokines and other inflammatory mediators in blood as
well as organ homogenates. Mice were treated daily with 5 mg/kg
pioglitazone in 0.5% methylcellulose/PBS via ip injections starting
on day 0 with the Ca infections. The control mice received vehicle
only. Weight loss was monitored every other day as a measure of
morbidity.
Determination of fungal burden
Mice were sacrificed and spleen, liver, kidneys, and brain were
removed aseptically at necropsy, rinsed with sterile PBS, weighted,
and placed in 1.5 ml sterile tissue lysis buffer (200 mM NaCl,
5 mM EDTA, 10 mM Tris, 10% glycerol, 16 protease inhibitor
cocktail (Roche)) on ice. The organs were aseptically homogenized
using an Ika T10 basic Ultra-Turrax homogenizer (Ika, Staufen).
Serial dilutions of homogenates were plated in triplicate on YPD
(1% yeast extract, 1% peptone, 2% dextrose) plates containing
ampicillin, tetracycline, and chloramphenicol. Colonies were
counted after 48 h of incubation at 30uC. The fungal burden
was calculated as cfus per gram of tissue.
Clinical parameters, haematology and histopathology
To assess kidney tissue damage, levels of blood urea (blood urea
nitrogen - BUN) were determined in serum samples by a routine
veterinarian diagnostics laboratory (InVitro GmbH). For haema-
tology, blood samples were collected in K-EDTA-coated tubes
(Sarstedt) and analysed with an automated blood counter (V-Sight,
A. Menarini). For histology, parts of organs were fixed with
buffered 4% paraformaldehyde, and paraffin-embedded sections
were stained with hematoxylin-eosin (HE) or periodic acid-Schiff
(PAS) stain according to standard protocols.
Cytokine measurements by ELISA
The amount of IFN-b released in cell culture supernatants was
assayed using the Verikine mouse IFN-b ELISA kit (R&D
systems). Serum IFN-a was measured using the Luminex system
with Procarta Cytokine Profiling Kits; TNF-a and IL-6 in serum
were determined using the Mouse CBA flex sets (BD Biosciences);
CCL7, KC, and MIP-2 using Procarta Immunoassays (Panomics-
Affymetrix); CCL2 using a commercial ELISA Set (Biolegend); all
according to the manufacturer’s instructions.
For cytokine quantification in tissues, organ homogenates of Ca-
infected mice prepared as described for fungal burden determi-
nation were centrifuged twice (1,5006g, 15 min, 4uC) and diluted
prior to measurement. Myeloperoxidase (MPO) was determined
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by the Mouse MPO ELISA kit (Hycult Biotechnology); IL-6 and
KC chemokine were measured using the Mouse CBA flex sets (BD
Biosciences); all conditions were according to the manufacturer’s
instructions.
Flow-cytometry analysis of immune cells
Blood preparation and leukocyte enrichment from kidneys were
performed as described in the supplemental material. Blood and
kidney leukocytes were stained with the appropriate combination
of FITC-labeled anti-Ly6G (1A8, Biolegend) or anti-CD3 (145-
2C11, BD Biosciences), PE-labeled anti-PDCA1 (eBio129c,
eBioscience), anti-CD4 (RM4-5, BD Biosciences), APC-Cy7-
labeled anti-CD45 (30-F11, BD Biosciences), PerCP-Cy5.5-
labeled anti-CD11c (N418, Biolegend), Pacific Blue-labeled anti-
Ly6C (HK1.4, Biolegend), BD Horizon-labeled CD11b (M1/70;
BD Biosciences) or anti-CD8 (53-6.7, BD Biosciences), after
blocking of Fc receptors with anti-CD32/CD16 (93, eBioscience).
Intracellular staining of iNOS was performed with anti-NOS2
(M-19, Santa Cruz) and DyLight 649-conjugated anti-rabbit IgG
(Jackson Immuno Research) according to the application guide-
lines of BD Bioscience. Anti-CCR2 (MC-21) was kindly provided
by Matthias Mack. Data were acquired using a FACSAria (BD
Biosciences) and analysed using the FlowJo software (Tree Star).
Leukocyte characterization was performed on gated CD45+ cells.
Leukocytes were further identified according to cell-specific
markers as listed in Table S1 in Text S1.
Innate immune cell isolation and Candida killing assay
For the preparation of exudate neutrophils and peritoneal
macrophages (Mphs), C57BL/6 mice were ip-injected with
0,5 ml 10% proteose peptone (Sigma, St. Louis, MO, USA)/
PBS. After 4 h (for neutrophils) or 3 days (for peritoneal
macrophages), the peritoneum was flushed with 7 ml PBS
containing 50 U/ml heparin to collect cells. For isolation of
resting Mphs, peritoneum of untreated mice was flushed. For
isolation of bone marrow resident neutrophils, bone marrow was
collected from mice. After lysis of red blood cells, samples were
separated on a discontinuous Percoll gradient: from bottom to
top 78%, 69%, and 52% Percoll (GE Healthcare). Gradient was
centrifuged at 15006g and 4uC for 30 min. Cells accumulating in
the interphase between the 78% and 69% Percoll layer were
collected as neutrophils. All different types of immune cells were
plated in RPMI supplemented with 10% heat-inactivated FCS
and used for co-culture with fungi.
For the in vitro Ca killing assay, innate immune cells were plated
in replicates at a density of 16105 cells/well of 96-well plates. Cells
were incubated with Ca at indicated MOIs and for indicated time.
After incubation, mammalian cells were lysed by addition of
Triton X 100 to a final concentration of 1%. After lysis, wells were
extensively scrapped, 26washed with PBS and surviving Ca was
determined by plating serial dilutions of the collected media and
washes in duplicates on YPD plates containing ampicillin (Sigma).
The percentage of killing was calculated according to the following
formulas (df = dilution factor):
% survival~df|cfu with immune cellð Þ
=df|cfu without immune cellð Þ|100
% killing~100%{percent survival
Intraperitoneal leukocyte recruitment
Male mice were injected intraperitoneally with 16107 Ca
colony-forming units (cfus). After 4–6 hours, peritoneal cells were
collected with sterile PBS, and the total cell number was assessed
in a CASY counter. Cells were stained for flow-cytometry analysis
with FITC-labeled anti-Ly6G (1A8, Biolegend), Pacific Blue-
labeled anti-Ly6C (HK1.4, Biolegend), and BD Horizon-labeled
CD11b (M1/70; BD Biosciences).
Reverse transcription and real-time PCR analysis
RNA sample preparation, reverse transcription and real-time
PCR were performed as described in the supplemental material.
Relative quantification was performed with the DDCt-method.
Expression level of the genes of interest were normalised to the
expression level of the housekeeping gene HPRT. Real-time PCR
data are expressed as fold increase of mRNA expression over
baseline levels (uninfected mice). All primers used in this study are
listed in Table S2 in Text S1.
Statistical analysis
Statistical analysis of data was performed using the Prism
graphing and analysis software (Graphpad). Survival data were
compared using the logrank test. Candida cfu data were analysed
using the non-parametric Mann-Whitney-test. Time-kinetic com-
parisons of WT and Ifnar12/2 mice data at every time point were
performed using Two-way ANOVA followed by a Bonferroni
post-test. Two-group comparisons were done with the Student’s t
test. In all cases, P,0.05 was considered significant. *p,0.05;
**p,0.01; ***p,0.001; ns, not significantly different.
Gene IDs
Bst2 (PDCA1): ENSMUSG00000046718, Ccl2: ENSMUSG-
00000035385, Ccl7: ENSMUSG00000035373, Ccr2: ENSMU-
SG00000049103, Cd4: ENSMUSG00000023274, Cd8a: ENSM-
USG00000053977, Cxcl1 (KC): ENSMUSG00000029380, H2-
D1 (MHC II): ENSMUSG00000073411, Havcr1 (KIM-1): ENS-
MUSG00000040405, Icam1: ENSMUSG00000037405, Ifna2:
ENSMUSG00000078354, Ifnar1: ENSMUSG00000022967, Ifn-
b1: ENSMUSG00000048806, Il1b: ENSMUSG00000027398,
Il6: ENSMUSG00000025746, Itgam (CD11b): ENSMUSG-
00000030786, Itgax (CD11c): ENSMUSG00000030789, Ly6c1:
ENSMUSG00000079018, Mapk14 (p38): ENSMUSG000000-
53436, Mpo: ENSMUSG00000009350, Nos2 (iNOS): ENSMU-
SG00000020826, Ptprc (CD45): ENSMUSG00000026395, Selp
(P-Selectin): ENSMUSG00000026580, Stat1: ENSMUSG0000-
0026104, Tnf: ENSMUSG00000024401
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Figure S1 The role of IFNs-I during experimental
candidiasis. (A) IFN-b release of WT or Ifnar12/2 BM-DCs
stimulated with Ca for 24 h. Data presented show the mean 6
SEM of 4 independent experiments. (B) Phosphorylated STAT1 of
lysates from WT or Ifnar12/2 BM-DCs stimulated with Ca for
2 h. Data presented is one representative of three independent
experimental repeats. Mice of the indicated genotype were iv
injected with a low dose of 0.56105 cfus Ca (C) or a high dose of
56105 cfus (D) and survival was monitored for a period of 21 days.
The data here are presented as Kaplan-Meier survival curves and
are from one experiment with a total number of 6 or 12 mice per
group, respectively. (E) Mice were injected with 0.56105 cfus Ca.
At indicated time points, Ca cfus in brain, spleen, and liver were
determined and expressed as cfus/g organ (n= 3 mice per group).
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Each symbol represents one mouse; horizontal bars indicate the
calculated median.
(TIF)
Figure S2 Immune cell recruitment to kidneys. Mice of
the indicated genotype were injected with a lethal dose of
16105 cfus Ca. At indicated time points, both kidneys were
collected. Kidney leukocytes were enriched and immune cell
populations characterized by multi-label flow cytometry. Graphs
show CD8+ T cells (A) and CD4+ T cells (B) as absolute numbers
per mouse kidneys (left panels) or as percentage of CD45+ cells
(right panels). Data presented show the mean 6 SEM of one
experiment with 5 mice per time point. (C) MPO concentrations
in kidney supernatants were measured by ELISA. Data presented
show the mean6 SEM of four independent experiments (n = 8–12
mice per group).
(TIF)
Figure S3 Recruitment and activation of inflammatory
monocytes requires IFN-I signalling. (A) WT BM-DCs were
pre-treated with either an a-IFNAR1 blocking antibody or an
unspecific isotype control prior to stimulation with heat-inactivat-
ed Ca. After 24 h, CCL2 CCL7, KC, and MIP-2 release was
determined by ELISA or a multiplex bead array system. Data
presented show the mean 6 SEM of three independent
experiments. (B) Mice of the indicated genotype were injected
with a lethal dose of 16105 cfus Ca. At indicated time points, BM
was collected and total RNA analysed for gene expression of Ccl2
and Ccl7. Data presented show the mean 6 SEM (n= 4–5 mice
per group). (C) BM-DCs of the indicated genotypes or (D) WT
BM-DCs pre-treated with either an a-IFNAR1 blocking antibody
or an unspecific isotype control were stimulated for 24 h with
heat-inactivated Ca. Cells were stained for the inflammatory DC
markers iNOS, PDCA1, CD11c, and MHCII. For analysis and
histogram presentation only Ly6C+ cells have been gated. Solid
lines; staining of Ly6C+ cells after Ca stimulation; shaded
histograms; staining of unstimulated culture. Data presented show
representatives of two independent experimental repeats.
(TIF)
Figure S4 Pioglitazone attenuates inflammatory host
responses. (A,C) WT mice were injected with a lethal dose of
16105 cfus Ca and treated daily with 5 mg/kg pioglitazone. At
indicated time points, blood and kidneys were collected. (A) Blood
samples were analyzed for the percentage of inflammatory
monocytes (left) or granulocytes (right) in total WBCs. Data
presented show the mean 6 SD of one representative experiment
out of two independent repeats (n = 3–5 mice per group). (B) BM-
DCs were pre-treated with 100 mM pioglitazone overnight and
stimulated the next day with heat-inactivated Ca for 24 h.
Expression of iNOS was determined by intracellular staining.
For analysis and histogram presentation only Ly6C+ cells have
been gated. Solid lines; staining of Ly6C+ cells after Ca
stimulation; shaded histograms; staining of unstimulated culture.
Bar diagram shows the quantification of iNOS+ cells of total
Ly6C+ cells, mean 6 SD (n= 4). (C) Sera concentrations of IL-6
(left) were measured using ELISA. Kidney total RNA was analysed
for gene expression of Ccl2. Data presented show the mean 6
SEM (n= 5–6 mice per group). (D) BM-DCs were pre-treated
overnight with indicated concentrations of pioglitazone and
stimulated with heat-inactivated Ca the next day. After 24 h of
Ca co-incubation, KC and MIP-2 release were measured by a
multiplex bead array system. Data presented show the mean 6
SEM of 3 independent experiments. (E) Cytotoxic effect of
pioglitazone. BM-DCs were pre-treated with varying concentra-
tions of pioglitazone for 24 h and cell viability was determined by
live-dead staining of cells. Data presented shows one representative
of two independent experimental repeats. (F) WT or Ifnar12/2
BM-DCs were pre-treated with 100 mM pioglitazone overnight
and stimulated the next day with heat-inactivated Ca. After 24 h,
CCL2 release was measured by ELISA. Data presented show the
mean 6 SD of 3 independent experiments.
(TIF)
Text S1 Supplemental information, including 4 Figures
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